Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
TipRanks Clinical-Trials-Auto-Generated Newsdesk
TipRanks Reporter
TipRanks’s Recent Articles
Gilead Sciences Completes Promising Study on Metastatic Colorectal Cancer Treatment
Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration with Arcus Biosciences,...
20h ago
GILD
Sanofi’s Rilzabrutinib Trial: A Potential Game-Changer for IgG4-related Disease
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Study Overview: Sanofi is conducting a Phase 3...
5d ago
SNYNF
AstraZeneca’s New Study on AZD0516: A Potential Game-Changer for Metastatic Prostate Cancer
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca is currently conducting a study titled ‘A...
5d ago
AZN
Medtronic’s Innovative Approach to Diabetic Neuropathy Pain: A Study Update
Medtronic (($MDT)) announced an update on their ongoing clinical study. Study Overview: Medtronic is conducting a study titled...
5d ago
MDT
Jazz Pharmaceuticals Completes Study on Promising HER2 Cancer Treatment
Jazz Pharmaceuticals (($JAZZ)) announced an update on their ongoing clinical study. Jazz Pharmaceuticals has recently completed a clinical...
5d ago
JAZZ
AbbVie’s Phase 2 Study on CLL/SLL Treatment: Key Updates and Market Impact
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 2 clinical study...
5d ago
ABBV
Eli Lilly and Cipla’s Diabetes Study: A Market Game Changer?
Eli Lilly And Company (($LLY)), Cipla Ltd (($IN:CIPLA)) announced an update on their ongoing clinical study. Study Overview:...
5d ago
LLY
Regeneron’s Cemiplimab Study: Real-World Insights and Market Impact
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: The Cemiplimab Survivorship Epidemiology (CASE)...
5d ago
REGN
HER-TEMPO Study: Real-World Insights on Trastuzumab Deruxtecan
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The HER-TEMPO study, officially titled ‘Real...
5d ago
AZN
AbbVie’s Venetoclax Study Completion: A Potential Boost for Investors
Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a clinical study titled ‘A...
5d ago
ABBV
GSK’s Asthma Study Update: Potential Market Impacts
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study...
5d ago
GSK
Eli Lilly’s Latest Study on Obesity Treatment: A Promising Update
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
5d ago
LLY
AstraZeneca’s AZD5004 Study Completion: Key Insights for Investors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca recently completed a Phase I study titled...
5d ago
AZN
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase...
7d ago
SNYNF
Sanofi’s Promising COPD Study: Lunsekimig’s Potential Impact
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase...
7d ago
SNYNF
GSK’s RSV Vaccine Study Update: Promising Developments for Older Adults
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) recently updated its clinical study on...
7d ago
GSK
AstraZeneca’s Tezepelumab Study: A New Hope for Severe Asthma Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has recently completed a significant clinical study...
7d ago
AZN
GSK’s NASH Study Completion: A Potential Game-Changer for Liver Disease Treatment
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) recently completed a Phase 2a clinical...
7d ago
GSK
GSK Advances Hepatitis B Treatment with Promising Study Update
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) recently updated its clinical study on...
7d ago
GSK
Eli Lilly’s New Diabetes Study: A Potential Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
11d ago
LLY
Sanofi’s New Study on SAR446597: A Potential Game-Changer for Age-related Macular Degeneration
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a Phase 1/2 clinical study...
11d ago
SNYNF
Eli Lilly’s New Study on Weight Reduction Drugs: A Potential Market Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
11d ago
LLY
AstraZeneca’s New Trial Targets Sepsis-Related Kidney Injury
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is launching a Phase IIa...
11d ago
AZN
AstraZeneca Launches New Study on NSCLC Treatment Patterns
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. In a recent update, AstraZeneca announced a new...
11d ago
AZN
AstraZeneca’s New Study Targets Improved Treatment for Elderly LBCL Patients
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase III...
11d ago
AZN
Regeneron and Bayer Complete Long-term Study on Retinopathy of Prematurity Treatments
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals, in collaboration with...
11d ago
REGN
Regeneron Completes Study on Aflibercept’s Safety in Real-World Settings
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently completed a...
11d ago
REGN
Trevi Therapeutics Completes Key Phase 1 Drug Interaction Study
Trevi Therapeutics (($TRVI)) announced an update on their ongoing clinical study. Trevi Therapeutics recently completed a Phase 1...
11d ago
TRVI
AstraZeneca’s OPTIMISE-CKD Study: Insights into Chronic Kidney Disease Management
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The OPTIMISE-CKD Study, officially titled A...
11d ago
AZN
Regeneron’s Odronextamab Study Update: A Potential Game-Changer in B-Cell Malignancies
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals recently updated its clinical study...
11d ago
REGN
AstraZeneca’s Latest Study on AZD5004: Key Insights for Investors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s recent clinical study, titled An...
11d ago
AZN
Eli Lilly’s New Study on Liver Disease: A Potential Game-Changer for Investors
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
12d ago
LLY
Eli Lilly’s New Study on Orforglipron: A Potential Game-Changer for Stress Urinary Incontinence
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
12d ago
LLY
Ipsen’s New Study on IPN60300: A Potential Game-Changer for Advanced Tumours
Ipsen (($GB:0MH6)) announced an update on their ongoing clinical study. Study Overview: Ipsen is conducting a clinical study...
12d ago
0MH6
Ipsen’s New Study on IPN01203: A Potential Game-Changer for Advanced Tumour Treatment
Ipsen (($GB:0MH6)) announced an update on their ongoing clinical study. Study Overview: Ipsen is conducting a study titled...
12d ago
0MH6
Eli Lilly’s New Study on LY4337713: A Potential Game-Changer for Cancer Treatment
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and...
12d ago
LLY
Eli Lilly’s Promising Phase 3 Study on Ovarian Cancer Treatment: A Potential Game-Changer
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is...
12d ago
LLY
AstraZeneca’s ATHENA Study: A New Chapter in Severe Asthma Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. The ATHENA Study, officially titled ‘ItAlian, Multicenter, Observational,...
12d ago
AZN
Alnylam and Regeneron Join Forces in Promising Alzheimer’s Study
Alnylam Pharmaceuticals (($ALNY)), Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Alnylam Pharmaceuticals,...
12d ago
ALNY
REGN
Eli Lilly Completes Phase 1 Study on Bimagrumab and Tirzepatide: Market Implications
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company recently...
12d ago
LLY
AstraZeneca’s CKD Study in Brazil: Key Insights and Market Impact
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca recently completed a study titled...
13d ago
AZN
AstraZeneca’s Olaparib Safety Study: Key Insights for Investors
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s study titled ‘A Multi-Centre, Prospective,...
13d ago
AZN
Avidity Biosciences’ Phase 2 Study on AOC 1001: A Potential Game-Changer for DM1 Treatment
Avidity Biosciences Inc (($RNA)) announced an update on their ongoing clinical study. Study Overview: Avidity Biosciences Inc. is...
13d ago
RNA
AstraZeneca’s AZD4144: Promising Obesity Treatment Under Study
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca recently completed a Phase I...
14d ago
AZN
Apyx Medical’s Renuvion APR System: Promising Results in Facelift Surgery Study
Apyx Medical (($APYX)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled ‘Histological...
15d ago
APYX
AstraZeneca and Icon Plc Launch Eplontersen Safety Study for Pregnant and Lactating Individuals
AstraZeneca (($AZN)), Icon Plc (($ICLR)) announced an update on their ongoing clinical study. AstraZeneca and Icon Plc have...
18d ago
AZN
ICLR
Ab Science’s Phase 3 ALS Trial: A Key Development for Investors
Ab Science (($ABSCF)) announced an update on their ongoing clinical study. Ab Science is spearheading a pivotal Phase...
18d ago
ABSCF
GSK’s New mRNA Flu Vaccine Study: What Investors Need to Know
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study...
18d ago
GSK
AstraZeneca’s Baxdrostat Study: A Potential Game-Changer for Resistant Hypertension
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s recent clinical study, officially titled...
18d ago
AZN
GSK’s Phase 1 Lupus Drug Trial Faces Suspension: Market Implications
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has launched a Phase 1 clinical...
18d ago
GSK
SHOW MORE
You need to enable JavaScript to run this app.
